19th Expert Committee on the Selection and Use of Essential Medicines: Applications (Sections 16-29)

• Sections 1-15

Section 16: Diuretics

Section 17: Gastrointestinal medicines

• Antiulcer medicines (Review) -- Adults

Section 18: Hormones

• Glibenclamide (Review) -- Adults
• Oral hypoglycemics (Review) -- Adults

Section 19: Immunologicals

Section 20: Muscle relaxants

Section 21: Ophthalmological preparations

• Azithromycin (Addition) -- Adults and Children
• Bevacizumab (Addition) -- Adults
• Ketorolac (Addition) -- Adults
• Ketotifen (Addition) -- Adults and Children
• Latanoprost (Addition) -- Adults
• Ofloxacin (Addition) -- Adults and Children

Section 22: Oxytocics and antioxytocics

• Misoprostol (Deletion) for PPH prevention -- Adults
• Misoprostol (New indication) -- Adults

Section 23: Peritoneal dialysis solution

Section 24: Psychotherapeutic medicines

• Chlorpromazine and haloperidol (Deletion) -- Children only
• Clozapine (Addition as complementary medicine) -- Adults
• Fluoxetine (Change to age restriction/Deletion from EMLc) -- Adults and Children
• Risperidone (Addition) -- Adults

Section 25: Medicines acting on the respiratory tract

Section 26: Solutions correcting water, electrolyte and acid-base disturbances

Section 27: Vitamins and minerals

• Calcium (Addition) -- Adults

Section 28: Ear, nose and throat conditions in children

• Ear, nose and throat (Review) -- Adults and Children
• Montelukast (Addition) -- Children

Section 29: Specific medicines for neonatal care

• Dexamethasone (New indication) -- Children

Section ??: Palliative care for children

• Palliative care (New section) -- Children